Holen Sie sich die Stockscreener-App
36.73
8.15%
-3.26
Akero Therapeutics Inc Aktie (AKRO) Neueste Nachrichten
Akero Therapeutics (NASDAQ:AKRO) Trading 7.3% HigherHere's Why - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Position Trimmed by Wellington Management Group LLP - MarketBeat
NEOS Investment Management LLC Has $894,000 Stock Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Liver Fibrosis Market Set to Grow Substantially Through 2034, - openPR.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Shareholders to Connect - markets.businessinsider.com
Akero Therapeutics Enters Oversold Territory (AKRO) - Nasdaq
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Akero Therapeutics, Inc. (AKRO) And Encourages Shareholders to Reach Out - markets.businessinsider.com
Teacher Retirement System of Texas Acquires 2,274 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World
Akero Therapeutics (NASDAQ:AKRO) Shares Gap Up on Insider Buying Activity - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Director G. Walmsley Graham Purchases 50,000 Shares - MarketBeat
Insider Buying: Akero Therapeutics, Inc. (NASDAQ:AKRO) Director Acquires 91,309 Shares of Stock - MarketBeat
Possible Bearish Signals With Akero Therapeutics Insiders Disposing Stock - simplywall.st
Akero Therapeutics (NASDAQ:AKRO) Stock Price Down 6.3%Time to Sell? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Akero Therapeutics, Inc. (AKRO) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com
Proficio Capital Partners LLC Takes Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
How To Trade (AKRO) - news.stocktradersdaily.com
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Akero Therapeutics Insider Bought Shares Worth $8,787,921, According to a Recent SEC Filing - MarketScreener
Simplify Asset Management Inc. Sells 19,089 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Acquired by Swiss National Bank - Defense World
Akero Therapeutics director Graham Walmsley buys $8.79m in stock By Investing.com - Investing.com South Africa
Akero Therapeutics director Graham Walmsley buys $8.79m in stock - Investing.com India
Akero Therapeutics (AKRO) Stock Price, News & Analysis - MarketBeat
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
Proficio Capital Partners LLC Invests $320,000 in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World
Intech Investment Management LLC Buys 20,795 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Yiheng Capital Management L.P. Sells 92,624 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
There is no way Akero Therapeutics Inc (AKRO) can keep these numbers up - SETE News
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Alumis and Kaken sign agreement in Japan for ESK-001 - Pharmaceutical Technology
Charles Schwab Investment Management Inc. Acquires 8,096 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands - Bluefield Daily Telegraph
Notice to Long-Term Shareholders of Akero Therapeutics, - GlobeNewswire
Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Integra Lifesciences Holdings Corporation (Nasdaq: IART); and Kyverna Therapeutics, Inc. (Nasdaq: KYTX): Grabar Law Office is I - TradingView
Comparing Rezolute (NASDAQ:RZLT) & Akero Therapeutics (NASDAQ:AKRO) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Investors to Connect - Markets Insider
Kennondale Capital Management LLC Acquires New Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Catriona Yale Sells 10,000 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock - MarketBeat
10 Health Care Stocks Whale Activity In Today's Session - Benzinga
Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock Position Raised by Charles Schwab Investment Management Inc. - Defense World
Bank of New York Mellon Corp Sells 6,414 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Stockholders to Inquire about Securities Investigation - Markets Insider
Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Bought by AlphaQuest LLC - MarketBeat
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):